Clinical trial
Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are…
NCT00334789 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00334789 |
|---|---|
| Title | Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery |
| Official title | A Phase 1 Trial of PXD101 in Combination With 13-cis-Retinoic Acid in Advanced Solid Tumor Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Adult Solid Neoplasm |
| Intervention type | Drug, Other |
| Interventions | Belinostat, Isotretinoin, Pharmacological Study |
| Enrollment | 51 |
| Start date | Jun 12, 2006 |
| Primary completion | Mar 29, 2018 |
| Completion | Mar 29, 2018 |
| First posted | Jun 8, 2006 |
| Last update posted | Apr 3, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: